A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
NCT00441116
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Alopecia
Interventions
DRUG:
Dutasteride 0.5mg oral tablets
Sponsor
GlaxoSmithKline